tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 122 are a BUY (84.14%), 23 are a HOLD (15.86%).
Analyst Emily Bodnar, currently employed carries an average stock price target met ratio of 21.25% that have a potential upside of 82.01% achieved within 52 days. Previously, Emily Bodnar worked at HC WAINWRIGHT.
Emily Bodnar’s has documented 297 price targets and ratings displayed on 17 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on OLMA, Olema Pharmaceuticals at 12-Dec-2024.
Analyst best performing recommendations are on RNAZ (TRANSCODE THERAPEUTICS).
The best stock recommendation documented was for RNAZ (TRANSCODE THERAPEUTICS) at 11/15/2024. The price target of $3 was fulfilled within 19 days with a profit of $2.66 (782.35%) receiving and performance score of 411.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$0.45 (0.95%)
$48
1 years 4 months 11 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
1 years 5 months 24 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
1 years 6 months ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
1 years 6 months ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
1 years 6 months ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
